CAS: 1026295-98-6
L-Lysinamide, N-acetyl-L-leucylglycyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-N6-(2,2,2-trifluoroacetyl)-
CAS:1026295-98-6
Formula:
C28H36F3N5O7
Peso molecolare:
611.6099
Ref: IN-DA0007YY
Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 12 Novembre 2024
(S)-2-(2-((S)-2-Acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)-6-(2,2,2-trifluoroacetamido)hexanamide
CAS:1026295-98-6
Please enquire for more information about (S)-2-(2-((S)-2-Acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)-6-(2,2,2-trifluoroacetamido)hexanamide including the price, delivery time and more detailed …
Formula:
C28H36F3N5O7
Purezza:
Min. 95%
Peso molecolare:
611.61 g/mol
Ref: 3D-BRB29598
250mg | Prezzo su richiesta | ||
500mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024
HDAC-IN-6
CAS:1026295-98-6
HDAC-IN-6 is an HDAC inhibitor, targeting HDAC2, HDAC3, HDAC4, HDAC5, HDAC7, HDAC8, and HDAC9.
Formula:
C28H36F3N5O7
Colore e forma:
Solid
Peso molecolare:
611.61
Ref: TM-T72012
25mg | 1.796,00 € | ||
50mg | 2.352,00 € | ||
100mg | 3.100,00 € |
Consegna stimata in Stati Uniti, il Martedì 14 Gennaio 2025